IL6 and rheumatoid arthritis: Nevertheless, LU8C-FP failed to inhibit IL-1β and IL-8 expression, which provide information leading to the use of this flavonoid to treat inflammatory diseases caused by IL-6 [98], such as colitis, diabetes, rheumatoid arthritis, cancer and cardiovascular diseases [99,100,101,102,103].